Literature DB >> 16772877

Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.

Masaki Yamamoto1, Nobuhiro Suzuki, Naoki Hatakeyama, Nobuo Mizue, Tsukasa Hori, Yuki Kuroiwa, Masato Hareyama, Takanori Oda, Tooru Kudoh, Akihiro Nui, Takashi Matsuno, Toshinori Hirama, Shigeaki Yokoyama, Jeffrey S Dome, Hiroyuki Tsutsumi.   

Abstract

The prognosis of stage IV malignant rhabdoid tumor of the kidney (MRTK) has been extremely poor. However, a combination of ICE (ifosfamide, carboplatin, and etoposide) and VDCy (vincristine, doxorubicin, and cyclophosphamide) was recently reported to be effective for metastatic MRTK. We describe a 21-month-old girl with stage IV MRTK who was successfully treated with ICE, VDCy, and radiotherapy. She remained well, without recurrence, 24 months after diagnosis. Alternating therapy with ICE and VDCy might become a standard regimen for stage IV MRTK, although further study is required to confirm its effectiveness.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16772877     DOI： 10.1097/01.mph.0000212901.84146.5a

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  Biology and Treatment of Rhabdoid Tumor.

Authors:  James I Geller; Jacquelyn J Roth; Jaclyn A Biegel
Journal:  Crit Rev Oncog       Date:  2015

2.  Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.

Authors:  Angela D Trobaugh-Lotrario; Gail E Tomlinson; Milton J Finegold; Lia Gore; James H Feusner
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

3.  A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor.

Authors:  Ruchika Sharma; Brenda J Kitchen; Rajen Mody; Aghiad Chamdin; Steven Bruch; Rama Jasty
Journal:  Pediatr Surg Int       Date:  2013-01-24       Impact factor: 1.827

4.  In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines.

Authors:  Melissa E Smith; Bhaskar C Das; Ganjam V Kalpana
Journal:  Cancer Cell Int       Date:  2011-09-27       Impact factor: 5.722

5.  Extra-cranial Malignant Rhabdoid Tumor in Children: A Single Institute Experience.

Authors:  Che Ry Hong; Hyoung Jin Kang; Hee Young Ju; Ji Won Lee; Hyery Kim; Sung-Hye Park; Il Han Kim; Kyung Duk Park; Hee Young Shin
Journal:  Cancer Res Treat       Date:  2015-01-02       Impact factor: 4.679

6.  Clinical and Molecular Differentiation Between Malignant Rhabdoid Tumor of the Kidney and Normal Tissue: A Two-Case Report.

Authors:  Chenghao Zhanghuang; Shuo Chen; Li Li; Zhen Yang; Yucheng Xie; Jiwei Li; Haoyu Tang; Xiaoli He; Liuyi Dong; Bing Yan
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

7.  Clinical and prognostic analysis of 42 children with malignant rhabdoid tumor of the kidney: a 7-year retrospective multi-center study.

Authors:  Chenghao Zhanghuang; Zhaoxia Zhang; Li Zeng; Bing Yan; Haoyu Tang; Jinkui Wang; Xing Liu; Guanghui Wei; Dawei He
Journal:  BMC Pediatr       Date:  2022-10-13       Impact factor: 2.567
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.